Suven Life Sciences Limited
Healthcare›Healthcare›Healthcare Services›Healthcare Research, Analytics & Technology
Key metrics
Price as of 2026-07-17
Stock price
₹325.90
Market cap
8,595 Cr
P/B
14.53
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4 Cr | 7 Cr | 9 Cr | 12 Cr | 1 Cr | 4 Cr | 2 Cr | 1 Cr | 2 Cr | 0.92 Cr | 3 Cr | 2 Cr |
| Operating expenses (approx.) | 26 Cr | 40 Cr | 83 Cr | 111 Cr | 28 Cr | 78 Cr | 39 Cr | 44 Cr | 52 Cr | 77 Cr | 103 Cr | 45 Cr |
| EBITDA | -22 Cr | -33 Cr | -73 Cr | -99 Cr | -27 Cr | -75 Cr | -38 Cr | -43 Cr | -50 Cr | -76 Cr | -101 Cr | -44 Cr |
| OPM % | -589.2% | -485.4% | -788.7% | -850.2% | -2637.2% | -2087.3% | -2334.0% | -2903.8% | -2686.5% | -8267.3% | -3580.9% | -2885.0% |
| Other income | 6 Cr | 11 Cr | 17 Cr | 21 Cr | 4 Cr | 8 Cr | 2 Cr | 1 Cr | 0.60 Cr | 4 Cr | 3 Cr | 7 Cr |
| Interest | 0.05 Cr | 0.09 Cr | 0.13 Cr | 0.16 Cr | 0.02 Cr | 0.04 Cr | 0.0079 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr | 0.16 Cr |
| Depreciation | 2 Cr | 3 Cr | 5 Cr | 7 Cr | 1 Cr | 3 Cr | 2 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 2 Cr |
| Profit before tax | -24 Cr | -37 Cr | -79 Cr | -106 Cr | -28 Cr | -78 Cr | -39 Cr | -44 Cr | -52 Cr | -77 Cr | -102 Cr | -46 Cr |
| Tax % | 0.0% | 0.0% | 0.0% | 0.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net profit | -24 Cr | -37 Cr | -79 Cr | -105 Cr | -28 Cr | -78 Cr | -39 Cr | -44 Cr | -52 Cr | -77 Cr | -102 Cr | -46 Cr |
| EPS (₹) | ₹-1.10 | ₹-1.69 | ₹-3.60 | ₹-4.82 | ₹-1.29 | ₹-3.56 | ₹-1.79 | ₹-2.02 | ₹-2.36 | ₹-3.48 | ₹-4.55 | ₹-2.02 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019Standalone only | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 664 Cr | 14 Cr | 13 Cr | 12 Cr | 14 Cr | 12 Cr | 7 Cr | 7 Cr | Sign in for TTM |
| Operating expenses (approx.) | 479 Cr | 116 Cr | 86 Cr | 129 Cr | 133 Cr | 132 Cr | 162 Cr | 278 Cr | Sign in for TTM |
| EBITDA | 185 Cr | -102 Cr | -72 Cr | -117 Cr | -120 Cr | -121 Cr | -155 Cr | -271 Cr | Sign in for TTM |
| OPM % | 27.8% | -705.4% | -536.5% | -988.4% | -885.5% | -1031.0% | -2326.9% | -3803.0% | Sign in for TTM |
| Other income | 24 Cr | 14 Cr | 8 Cr | 5 Cr | 8 Cr | 21 Cr | 11 Cr | 14 Cr | Sign in for TTM |
| Interest | 4 Cr | 0.55 Cr | 0.82 Cr | 0.53 Cr | 0.29 Cr | 0.16 Cr | 0.05 Cr | 0.16 Cr | Sign in for TTM |
| Depreciation | 22 Cr | 4 Cr | 4 Cr | 4 Cr | 7 Cr | 7 Cr | 6 Cr | 6 Cr | Sign in for TTM |
| Profit before tax | 159 Cr | -106 Cr | -77 Cr | -122 Cr | -118 Cr | -106 Cr | -161 Cr | -276 Cr | Sign in for TTM |
| Tax % | 45.2% | 11.5% | 6.9% | 0.0% | 0.0% | 0.9% | 0.0% | 0.0% | Sign in for TTM |
| Net profit | 87 Cr | -94 Cr | -72 Cr | -122 Cr | -118 Cr | -105 Cr | -161 Cr | -276 Cr | Sign in for TTM |
| EPS (₹) | ₹6.83 | ₹-2.01 | ₹-5.67 | ₹-9.57 | ₹-6.63 | ₹-4.82 | ₹-7.37 | ₹-12.13 | Sign in for TTM |
| Dividend payout % | — | — | — | — | — | — | — | — | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019Standalone only | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 13 Cr | 13 Cr | 13 Cr | 15 Cr | 22 Cr | 22 Cr | 22 Cr | 26 Cr |
| Reserves | 818 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr | 354 Cr | 248 Cr | 88 Cr | 565 Cr |
| Borrowings | 37 Cr | 1 Cr | 0.39 Cr | 0.48 Cr | — | — | — | — |
| Other liabilities | 144 Cr | 21 Cr | 13 Cr | 10 Cr | 14 Cr | 15 Cr | 25 Cr | 33 Cr |
| Total liabilities | 1,175 Cr | 410 Cr | 415 Cr | 486 Cr | 389 Cr | 285 Cr | 135 Cr | 624 Cr |
| Fixed assets (net) | 291 Cr | 21 Cr | 18 Cr | 35 Cr | 36 Cr | 27 Cr | 59 Cr | 56 Cr |
| CWIP | 111 Cr | — | 5 Cr | 4 Cr | 0.0000 Cr | 0.0000 Cr | 0.0097 Cr | 4 Cr |
| Investments | 366 Cr | 242 Cr | 295 Cr | 426 Cr | 46 Cr | 76 Cr | 22 Cr | 0.0000 Cr |
| Other assets | 623 Cr | 94 Cr | 136 Cr | 64 Cr | 252 Cr | 257 Cr | 75 Cr | 547 Cr |
| Total assets | 1,175 Cr | 410 Cr | 415 Cr | 486 Cr | 389 Cr | 285 Cr | 135 Cr | 624 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019Standalone only | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | -128 Cr | -208 Cr | -83 Cr | -154 Cr | -302 Cr |
| Cash from investing | — | — | — | -22 Cr | -156 Cr | 62 Cr | 155 Cr | -462 Cr |
| Cash from financing | — | — | — | 146 Cr | 396 Cr | -1 Cr | -0.76 Cr | 757 Cr |
| Net cash flow | — | — | — | -4 Cr | 32 Cr | -22 Cr | 0.09 Cr | -7 Cr |
| Free cash flow (OCF − Capex) | — | — | — | -147 Cr | -211 Cr | -80 Cr | -191 Cr | -307 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019Standalone only | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 19.6% | -831.6% | -602.3% | -835.5% | -33.7% | -47.0% | -146.1% | -46.7% |
| ROE % | 10.5% | -740.2% | 0.0% | 0.0% | 0.0% | -38.9% | -146.1% | -46.7% |
| Debtor days | 82 | 57 | 48 | 40 | 22 | 40 | — | — |
| Inventory days | 280 | 0 | 4 | 1 | 0 | 22 | 13 | 5 |
| Days payable | 108 | 146 | 81 | 61 | 45 | 65 | — | — |
| Cash conversion cycle | 254 | -89 | -29 | -20 | -23 | -2 | 13 | 5 |
| Debt / equity | 0.04 | 0.0028 | 0.0010 | 0.0010 | — | — | — | — |
| Current ratio | 5.08 | 5.19 | 10.25 | 9.44 | 22.61 | 18.99 | 3.21 | 17.69 |
| Net debt / EBITDA | 0.00 | — | — | — | — | — | — | — |
Compare with peers
Loading peers…